[Featured Stock] CJ CheilJedang Subsidiary CJ Bioscience Hits Upper Limit for Second Day

CJ CheilJedang's subsidiary CJ Bioscience has recorded the upper price limit for two consecutive days.

At 9:41 AM on the 20th, CJ Bioscience was trading at 14,780 KRW, up 29.99% from the previous day.

The parent company, CJ CheilJedang, is reportedly contacting acquisition candidates by appointing Morgan Stanley as the lead underwriter to sell its bio business division.

This content was produced with the assistance of AI translation services.